Form D — Verrica Pharmaceuticals Inc.
0001231919-25-000594 · filed 2025-12-10
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $50,017,383
- Total sold
- $50,017,383
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Verrica Pharmaceuticals Inc.
- CIK
- 1660334
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 44 W. Gay St., Suite 400
WEST CHESTER, PA 19380 - Phone
- 484-453-3300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jayson Rieger · Executive OfficerWest Chester, PA Find on LinkedIn ↗
-
John Kirby · Executive OfficerWest Chester, PA Find on LinkedIn ↗
-
David Zawitz · Executive OfficerWest Chester, PA Find on LinkedIn ↗
-
Noah Rosenberg · Executive OfficerWest Chester, PA Find on LinkedIn ↗
-
Paul B. Manning · DirectorWest Chester, PA Find on LinkedIn ↗
-
Lawrence Eichenfield · DirectorWest Chester, PA Find on LinkedIn ↗
-
Diem Nguyen · DirectorWest Chester, PA Find on LinkedIn ↗
-
Mark Prygocki · DirectorWest Chester, PA Find on LinkedIn ↗
-
Sean Stalfort · DirectorWest Chester, PA Find on LinkedIn ↗
-
Gavin Corcoran · DirectorWest Chester, PA Find on LinkedIn ↗
View original on SEC EDGAR.